— Know what they know.
Not Investment Advice

VERU NASDAQ

Veru Inc.
1W: -1.2% 1M: -8.7% 3M: -11.3% YTD: +10.6% 1Y: -35.5% 3Y: -67.8% 5Y: -97.2%
$2.51
-0.03 (-1.18%)
 
Weekly Expected Move ±5.3%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 44 · $40.3M mcap · 14M float · 14.39% daily turnover · Short 48% of daily vol

Cash Flow Trends

Operating Cash Flow
-$30M -38.6% ▼
Capital Expenditures
$1K +99.3% ▲
5Y CAGR: -60.0%
Free Cash Flow
-$30M -37.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$9M -159.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$7M-$84M-$93M-$38M-$23M
Depreciation & Amort.$211K$210K$270K$268K$152K
Stock-Based Comp.$5M$11M$18M$14M$8M
Change in Working Capital-$7M$26M-$15M$222K-$4M
Other Non-Cash Items-$17M-$1M$2M$2M-$11M
Operating Cash Flow-$16M-$48M-$88M-$22M-$30M
— Investing Activities —
Capital Expenditures-$377K-$733K-$666K-$158K-$1K
Acquisitions (Net)$15M$5M$0$0$25M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$393K
Other Investing$0$0$7M$305K$0
Investing Cash Flow$15M$4M$6M$146K$25M
— Financing Activities —
Net Debt Issuance-$19K-$9K$133K-$133K-$4M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$2M$0$5M$2M$0
Financing Cash Flow$110M$1M$11M$37M-$4M
Net Change in Cash$109M-$42M-$71M$15M-$9M
Cash End of Period$122M$80M$10M$25M$16M
Free Cash Flow-$16M-$48M-$89M-$22M-$30M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms